APA (7th ed.) Citation

Lin, Y., Li, C., Chen, Y., Gao, J., Li, J., Huang, C., . . . Yan, S. (2025). RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington's disease models. Molecular Neurodegeneration, 20(1), 1. https://doi.org/10.1186/s13024-024-00794-w

Chicago Style (17th ed.) Citation

Lin, Yingqi, et al. "RNA-Targeting CRISPR/CasRx System Relieves Disease Symptoms in Huntington's Disease Models." Molecular Neurodegeneration 20, no. 1 (2025): 1. https://doi.org/10.1186/s13024-024-00794-w.

MLA (9th ed.) Citation

Lin, Yingqi, et al. "RNA-Targeting CRISPR/CasRx System Relieves Disease Symptoms in Huntington's Disease Models." Molecular Neurodegeneration, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13024-024-00794-w.